NYSE · Medical Care Facilities · USD
Guardian Pharmacy Services, Inc. (GRDN) Stock Analysis
Guardian Pharmacy Services, Inc. (GRDN) is a Medical Care Facilities stock listed on NYSE and quoted in US Dollar.
Last Updated: October 21, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
GRDN Key Statistics
As of Oct 21, 2026Trading
- Open
- $41.58
- Previous Close
- $41.87
- Day's Range
- 38.91–41.99
- 52-Week Range
- 26.34–48.33
- Volume
- 429.33K
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 0.02
Valuation
- Market Cap
- $2.47B
- P/E Ratio
- 37.84
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 27.18
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 1.69
- EPS (ttm)Profit attributable to each share over the last twelve months.
- 1.03
Financials (FY)
- Revenue (FY)
- $1.45B+17.93%
- Net Income (FY)
- $49.22M
- Profit marginThe share of revenue left as profit after all costs and taxes.
- 4.50%
- Shares Outstanding
- 63.32M
- 1-Year Return
- +44.10%
Dividend and dates
- Earnings Date
- November 5, 2026
- Avg Volume
- 499.54K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
As of October 21, 2026, GRDN closed at $38.98, +44.10% over 1 year.
Guardian Pharmacy Services, Inc. (GRDN) has a market capitalization of $2.47B.
In fiscal 2025, GRDN reported revenue of $1.45B.
GRDN Stock Return by Calendar Year
Guardian Pharmacy Services, Inc. (GRDN) return since Sep 2024: what $10,000 became
- 1 year
- $10,000 $14,410
- +44.10%
- Since Sep 2024
- $10,000 $24,362
- +143.62%
If you had invested $10,000 in Guardian Pharmacy Services, Inc. (GRDN) at the close on September 26, 2024, the earliest close on record here, it would have been worth $24,362 at the close on October 21, 2026: +143.62% in total, +53.85% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | +29.54% |
| 2025 | +48.52% |
| 2024 (partial year) | +26.63% |
As of October 21, 2026.
GRDN Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $1.45B | $49.22M | 3.4% |
| 2024 | $1.23B | −$87.29M | −7.1% |
| 2023 | $1.05B | $23.90M | 2.3% |
| 2022 | $908.91M | $35.42M | 3.9% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $1.45B | $292.72M | $72.70M | $49.22M | 3.4% |
| 2024 | $1.23B | $244.37M | −$62.92M | −$87.29M | −7.1% |
| 2023 | $1.05B | $208.31M | $40.95M | $23.90M | 2.3% |
| 2022 | $908.91M | $185.87M | $51.99M | $35.42M | 3.9% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
GRDN Valuation vs Medical Care Facilities Median
Median of 54 stocks| Metric | GRDN | Medical Care Facilities median | vs median |
|---|---|---|---|
| P/E | 37.84 | 20.67 | 83% above |
| P/S ratio | 1.69 | 0.87 | 94% above |
| Profit margin | 4.50% | 3.19% | 1.3 pts above |
Medians across 54 Medical Care Facilities stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.
Recent News
Transcript: Guardian Pharmacy Service Q2 2026 Earnings Conference Call
BenzingaZacks.com featured highlights include CNXN, ECG, GRDN, EXPD and PBF
YahooGuardian Pharmacy Services: Slowing Growth In H2 2026
SeekingAlphaKeybanc Initiates Coverage of Guardian Pharmacy Services at Overweight
FintelKeybanc Initiates Coverage On Guardian Pharmacy Service with Overweight Rating, Announces Price Target of $52
BenzingaTruist Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $51
Benzinga
All 13 articles ↓Show fewer ↑
Guardian Pharmacy Services Acquires Assets of Tennessee-Based Nautilus Pharmacy
YahooGuardian Pharmacy Services (GRDN) Q2 2026 Earnings Call Transcript
The Motley FoolOppenheimer Maintains Outperform on Guardian Pharmacy Service, Raises Price Target to $49
BenzingaGuardian Pharmacy Services, Inc. (GRDN) Q2 2026 Earnings Call Transcript
SeekingAlphaGuardian Pharmacy Services (NYSE:GRDN) Beats Q2 EPS, Raises Full-Year Guidance
ChartMillGuardian Pharmacy Service Q2 Adj. EPS $0.29 Beats $0.27 Estimate, Sales $351.768M Beat $340.045M Estimate
BenzingaGuardian Pharmacy Service Raises FY2026 Sales Guidance from $1.400B-$1.420B to $1.430B-$1.450B vs $1.415B Est
Benzinga
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.
Related Medical Care Facilities Stocks
HCA Healthcare, Inc.
$99.46B
THCTenet Healthcare Corporation
$21.67B
EHCEncompass Health Corporation
$11.88B
FMSFresenius Medical Care AG
$11.47B
DVADaVita Inc.
$11.28B
UHSUniversal Health Services, Inc.
$10.78B
Popular Healthcare Stocks
Eli Lilly and Company
$1.13T
JNJJohnson & Johnson
$621.22B
ABBVAbbVie Inc.
$503.27B
UNHUnitedHealth Group Incorporated
$374.30B
MRKMerck & Co., Inc.
$369.78B











